» Articles » PMID: 26284476

A Bird's Eye View of NK Cell Receptor Interactions with Their MHC Class I Ligands

Overview
Journal Immunol Rev
Date 2015 Aug 19
PMID 26284476
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

The surveillance of target cells by natural killer (NK) cells utilizes an ensemble of inhibitory and activating receptors, many of which interact with major histocompatibility complex (MHC) class I molecules. NK cell recognition of MHC class I proteins is important developmentally for the acquisition of full NK cell effector capacity and during target cell recognition, where the engagement of inhibitory receptors and MHC class I molecules attenuates NK cell activation. Human NK cells have evolved two broad strategies for recognition of human leukocyte antigen (HLA) class I molecules: (i) direct recognition of polymorphic classical HLA class I proteins by diverse receptor families such as the killer cell immunoglobulin-like receptors (KIRs), and (ii) indirect recognition of conserved sets of HLA class I-derived peptides displayed on the non-classical HLA-E for recognition by CD94-NKG2 receptors. In this review, we assess the structural basis for the interaction between these NK receptors and their HLA class I ligands and, using the suite of published KIR and CD94-NKG2 ternary complexes, highlight the features that allow NK cells to orchestrate the recognition of a range of different HLA class I proteins.

Citing Articles

Melatonin enhances NK cell function in aged mice by increasing T-bet expression via the JAK3-STAT5 signaling pathway.

Liang C, Song R, Zhang J, Yao J, Guan Z, Zeng X Immun Ageing. 2024; 21(1):59.

PMID: 39237911 PMC: 11375890. DOI: 10.1186/s12979-024-00459-8.


HLA and KIR genetic association and NK cells in anti-NMDAR encephalitis.

Peris Sempere V, Luo G, Muniz-Castrillo S, Pinto A, Picard G, Rogemond V Front Immunol. 2024; 15:1423149.

PMID: 39050850 PMC: 11266021. DOI: 10.3389/fimmu.2024.1423149.


CRISPR-Cas9 screening reveals a distinct class of MHC-I binders with precise HLA-peptide recognition.

Schoufour T, van der Plas-van Duijn A, Derksen I, Melgers M, van Veenendaal J, Lensen C iScience. 2024; 27(6):110120.

PMID: 38939106 PMC: 11209011. DOI: 10.1016/j.isci.2024.110120.


The complex HLA-E-nonapeptide in Behçet disease.

Castano-Nunez A, Montes-Cano M, Garcia-Lozano J, Ortego-Centeno N, Garcia-Hernandez F, Espinosa G Front Immunol. 2023; 14:1080047.

PMID: 37638008 PMC: 10449640. DOI: 10.3389/fimmu.2023.1080047.


Exceptional diversity of KIR and HLA class I in Egypt.

Montero-Martin G, Kichula K, Misra M, Vargas L, Marin W, Hollenbach J HLA. 2023; 103(1):e15177.

PMID: 37528739 PMC: 11068459. DOI: 10.1111/tan.15177.